APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Peripheral Vasodilator Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Peripheral Vasodilator Drugs Market Analysis and Forecast 2026-2032

Report ID 174023870223 December 2025206 pages

Choose your research edition.

Industry ResearchPeripheral Vasodilator Drugs Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Peripheral Vasodilator Drugs Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Peripheral Vasodilator Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peripheral Vasodilator Drugs Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Peripheral Vasodilator Drugs Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Peripheral Vasodilator Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Peripheral Vasodilator Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Peripheral Vasodilator Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Peripheral Vasodilator Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Peripheral Vasodilator Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Peripheral Vasodilator Drugs include Endovastec, Aotecar Medical-B, Tibet Cheezheng Tibetan Medicine Co., Ltd, Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Pfizer, Inc., GSK plc and Bayer AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Peripheral Vasodilator Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Peripheral Vasodilator Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Peripheral Vasodilator Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Peripheral Vasodilator Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Peripheral Vasodilator Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Peripheral Vasodilator Drugs sales, projected growth trends, production technology, application and end-user industry.

Peripheral Vasodilator Drugs Segment by Company

Endovastec

Aotecar Medical-B

Tibet Cheezheng Tibetan Medicine Co., Ltd

Teva Pharmaceutical Industries Ltd.

Sanofi

Novartis AG

Pfizer, Inc.

GSK plc

Bayer AG

Bat Medical

AstraZeneca

Viatris, Inc.

Sun Pharmaceutical Industries Ltd.

Merck & Co., Inc.

Lupin

Bristol-Myers Squibb Company

Boehringer Ingelheim International GmbH

Abbott Laboratories

Peripheral Vasodilator Drugs Segment by Type

Alpha-adrenergic Blockers

Calcium Channel Blockers

Potassium Channel Activators

Others

Peripheral Vasodilator Drugs Segment by Application

Hospital

Retail Pharmacies

Others

Peripheral Vasodilator Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peripheral Vasodilator Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peripheral Vasodilator Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peripheral Vasodilator Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Peripheral Vasodilator Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Peripheral Vasodilator Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peripheral Vasodilator Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Peripheral Vasodilator Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Alpha-adrenergic Blockers Major Manufacturers Table 3. Calcium Channel Blockers Major Manufacturers Table 4. Potassium Channel Activators Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Peripheral Vasodilator Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Retail Pharmacies Major Manufacturers Table 9. Others Major Manufacturers Table 10. Peripheral Vasodilator Drugs Industry Trends Table 11. Peripheral Vasodilator Drugs Industry Drivers Table 12. Peripheral Vasodilator Drugs Industry Opportunities and Challenges Table 13. Peripheral Vasodilator Drugs Industry Restraints Table 14. Global Peripheral Vasodilator Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Peripheral Vasodilator Drugs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Peripheral Vasodilator Drugs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Peripheral Vasodilator Drugs Revenue Market Share by Region (2021-2026) Table 18. Global Peripheral Vasodilator Drugs Revenue Market Share by Region (2027-2032) Table 19. Global Peripheral Vasodilator Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Peripheral Vasodilator Drugs Sales by Region (2021-2026) & (k units) Table 21. Global Peripheral Vasodilator Drugs Sales by Region (2027-2032) & (k units) Table 22. Global Peripheral Vasodilator Drugs Sales Market Share by Region (2021-2026) Table 23. Global Peripheral Vasodilator Drugs Sales Market Share by Region (2027-2032) Table 24. Global Peripheral Vasodilator Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Peripheral Vasodilator Drugs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Peripheral Vasodilator Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Peripheral Vasodilator Drugs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Peripheral Vasodilator Drugs Sales Price (USD/unit) of Manufacturers (2021-2026) Table 29. Global Peripheral Vasodilator Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Peripheral Vasodilator Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Peripheral Vasodilator Drugs Manufacturers, Product Type & Application Table 32. Global Peripheral Vasodilator Drugs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Peripheral Vasodilator Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Peripheral Vasodilator Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Peripheral Vasodilator Drugs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Peripheral Vasodilator Drugs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Peripheral Vasodilator Drugs Revenue Market Share by Type (2021-2026) Table 39. Global Peripheral Vasodilator Drugs Revenue Market Share by Type (2027-2032) Table 40. Global Peripheral Vasodilator Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (k units) Table 42. Global Peripheral Vasodilator Drugs Sales by Type (2027-2032) & (k units) Table 43. Global Peripheral Vasodilator Drugs Sales Market Share by Type (2021-2026) Table 44. Global Peripheral Vasodilator Drugs Sales Market Share by Type (2027-2032) Table 45. Global Peripheral Vasodilator Drugs Price by Type (2021-2026) & (USD/unit) Table 46. Global Peripheral Vasodilator Drugs Price by Type (2027-2032) & (USD/unit) Table 47. Global Peripheral Vasodilator Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Peripheral Vasodilator Drugs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Peripheral Vasodilator Drugs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Peripheral Vasodilator Drugs Revenue Market Share by Application (2021-2026) Table 51. Global Peripheral Vasodilator Drugs Revenue Market Share by Application (2027-2032) Table 52. Global Peripheral Vasodilator Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (k units) Table 54. Global Peripheral Vasodilator Drugs Sales by Application (2027-2032) & (k units) Table 55. Global Peripheral Vasodilator Drugs Sales Market Share by Application (2021-2026) Table 56. Global Peripheral Vasodilator Drugs Sales Market Share by Application (2027-2032) Table 57. Global Peripheral Vasodilator Drugs Price by Application (2021-2026) & (USD/unit) Table 58. Global Peripheral Vasodilator Drugs Price by Application (2027-2032) & (USD/unit) Table 59. Endovastec Company Information Table 60. Endovastec Business Overview Table 61. Endovastec Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 62. Endovastec Peripheral Vasodilator Drugs Product Portfolio Table 63. Endovastec Recent Development Table 64. Aotecar Medical-B Company Information Table 65. Aotecar Medical-B Business Overview Table 66. Aotecar Medical-B Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Aotecar Medical-B Peripheral Vasodilator Drugs Product Portfolio Table 68. Aotecar Medical-B Recent Development Table 69. Tibet Cheezheng Tibetan Medicine Co., Ltd Company Information Table 70. Tibet Cheezheng Tibetan Medicine Co., Ltd Business Overview Table 71. Tibet Cheezheng Tibetan Medicine Co., Ltd Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Tibet Cheezheng Tibetan Medicine Co., Ltd Peripheral Vasodilator Drugs Product Portfolio Table 73. Tibet Cheezheng Tibetan Medicine Co., Ltd Recent Development Table 74. Teva Pharmaceutical Industries Ltd. Company Information Table 75. Teva Pharmaceutical Industries Ltd. Business Overview Table 76. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product Portfolio Table 78. Teva Pharmaceutical Industries Ltd. Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Sanofi Peripheral Vasodilator Drugs Product Portfolio Table 83. Sanofi Recent Development Table 84. Novartis AG Company Information Table 85. Novartis AG Business Overview Table 86. Novartis AG Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Novartis AG Peripheral Vasodilator Drugs Product Portfolio Table 88. Novartis AG Recent Development Table 89. Pfizer, Inc. Company Information Table 90. Pfizer, Inc. Business Overview Table 91. Pfizer, Inc. Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Pfizer, Inc. Peripheral Vasodilator Drugs Product Portfolio Table 93. Pfizer, Inc. Recent Development Table 94. GSK plc Company Information Table 95. GSK plc Business Overview Table 96. GSK plc Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. GSK plc Peripheral Vasodilator Drugs Product Portfolio Table 98. GSK plc Recent Development Table 99. Bayer AG Company Information Table 100. Bayer AG Business Overview Table 101. Bayer AG Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Bayer AG Peripheral Vasodilator Drugs Product Portfolio Table 103. Bayer AG Recent Development Table 104. Bat Medical Company Information Table 105. Bat Medical Business Overview Table 106. Bat Medical Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Bat Medical Peripheral Vasodilator Drugs Product Portfolio Table 108. Bat Medical Recent Development Table 109. AstraZeneca Company Information Table 110. AstraZeneca Business Overview Table 111. AstraZeneca Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. AstraZeneca Peripheral Vasodilator Drugs Product Portfolio Table 113. AstraZeneca Recent Development Table 114. Viatris, Inc. Company Information Table 115. Viatris, Inc. Business Overview Table 116. Viatris, Inc. Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Viatris, Inc. Peripheral Vasodilator Drugs Product Portfolio Table 118. Viatris, Inc. Recent Development Table 119. Sun Pharmaceutical Industries Ltd. Company Information Table 120. Sun Pharmaceutical Industries Ltd. Business Overview Table 121. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product Portfolio Table 123. Sun Pharmaceutical Industries Ltd. Recent Development Table 124. Merck & Co., Inc. Company Information Table 125. Merck & Co., Inc. Business Overview Table 126. Merck & Co., Inc. Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Merck & Co., Inc. Peripheral Vasodilator Drugs Product Portfolio Table 128. Merck & Co., Inc. Recent Development Table 129. Lupin Company Information Table 130. Lupin Business Overview Table 131. Lupin Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Lupin Peripheral Vasodilator Drugs Product Portfolio Table 133. Lupin Recent Development Table 134. Bristol-Myers Squibb Company Company Information Table 135. Bristol-Myers Squibb Company Business Overview Table 136. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Product Portfolio Table 138. Bristol-Myers Squibb Company Recent Development Table 139. Boehringer Ingelheim International GmbH Company Information Table 140. Boehringer Ingelheim International GmbH Business Overview Table 141. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Product Portfolio Table 143. Boehringer Ingelheim International GmbH Recent Development Table 144. Abbott Laboratories Company Information Table 145. Abbott Laboratories Business Overview Table 146. Abbott Laboratories Peripheral Vasodilator Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Abbott Laboratories Peripheral Vasodilator Drugs Product Portfolio Table 148. Abbott Laboratories Recent Development Table 149. North America Peripheral Vasodilator Drugs Revenue by Type (2021-2026) & (US$ Million) Table 150. North America Peripheral Vasodilator Drugs Revenue by Type (2027-2032) & (US$ Million) Table 151. North America Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (k units) Table 152. North America Peripheral Vasodilator Drugs Sales by Type (2027-2032) & (k units) Table 153. North America Peripheral Vasodilator Drugs Sales Price by Type (2021-2026) & (USD/unit) Table 154. North America Peripheral Vasodilator Drugs Sales Price by Type (2027-2032) & (USD/unit) Table 155. North America Peripheral Vasodilator Drugs Revenue by Application (2021-2026) & (US$ Million) Table 156. North America Peripheral Vasodilator Drugs Revenue by Application (2027-2032) & (US$ Million) Table 157. North America Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (k units) Table 158. North America Peripheral Vasodilator Drugs Sales by Application (2027-2032) & (k units) Table 159. North America Peripheral Vasodilator Drugs Sales Price by Application (2021-2026) & (USD/unit) Table 160. North America Peripheral Vasodilator Drugs Sales Price by Application (2027-2032) & (USD/unit) Table 161. North America Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. North America Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. North America Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. North America Peripheral Vasodilator Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 165. North America Peripheral Vasodilator Drugs Sales by Country (2021-2026) & (k units) Table 166. North America Peripheral Vasodilator Drugs Sales by Country (2027-2032) & (k units) Table 167. North America Peripheral Vasodilator Drugs Sales Price by Country (2021-2026) & (USD/unit) Table 168. North America Peripheral Vasodilator Drugs Sales Price by Country (2027-2032) & (USD/unit) Table 169. United States Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 170. Canada Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 171. Mexico Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 172. Europe Peripheral Vasodilator Drugs Revenue by Type (2021-2026) & (US$ Million) Table 173. Europe Peripheral Vasodilator Drugs Revenue by Type (2027-2032) & (US$ Million) Table 174. Europe Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (k units) Table 175. Europe Peripheral Vasodilator Drugs Sales by Type (2027-2032) & (k units) Table 176. Europe Peripheral Vasodilator Drugs Sales Price by Type (2021-2026) & (USD/unit) Table 177. Europe Peripheral Vasodilator Drugs Sales Price by Type (2027-2032) & (USD/unit) Table 178. Europe Peripheral Vasodilator Drugs Revenue by Application (2021-2026) & (US$ Million) Table 179. Europe Peripheral Vasodilator Drugs Revenue by Application (2027-2032) & (US$ Million) Table 180. Europe Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (k units) Table 181. Europe Peripheral Vasodilator Drugs Sales by Application (2027-2032) & (k units) Table 182. Europe Peripheral Vasodilator Drugs Sales Price by Application (2021-2026) & (USD/unit) Table 183. Europe Peripheral Vasodilator Drugs Sales Price by Application (2027-2032) & (USD/unit) Table 184. Europe Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Europe Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Europe Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Europe Peripheral Vasodilator Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 188. Europe Peripheral Vasodilator Drugs Sales by Country (2021-2026) & (k units) Table 189. Europe Peripheral Vasodilator Drugs Sales by Country (2027-2032) & (k units) Table 190. Europe Peripheral Vasodilator Drugs Sales Price by Country (2021-2026) & (USD/unit) Table 191. Europe Peripheral Vasodilator Drugs Sales Price by Country (2027-2032) & (USD/unit) Table 192. Germany Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 193. France Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 194. U.K. Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 195. Italy Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 196. Russia Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 197. Spain Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 198. Netherlands Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 199. Switzerland Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 200. Sweden Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 201. Poland Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 202. China Peripheral Vasodilator Drugs Revenue by Type (2021-2026) & (US$ Million) Table 203. China Peripheral Vasodilator Drugs Revenue by Type (2027-2032) & (US$ Million) Table 204. China Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (k units) Table 205. China Peripheral Vasodilator Drugs Sales by Type (2027-2032) & (k units) Table 206. China Peripheral Vasodilator Drugs Sales Price by Type (2021-2026) & (USD/unit) Table 207. China Peripheral Vasodilator Drugs Sales Price by Type (2027-2032) & (USD/unit) Table 208. China Peripheral Vasodilator Drugs Revenue by Application (2021-2026) & (US$ Million) Table 209. China Peripheral Vasodilator Drugs Revenue by Application (2027-2032) & (US$ Million) Table 210. China Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (k units) Table 211. China Peripheral Vasodilator Drugs Sales by Application (2027-2032) & (k units) Table 212. China Peripheral Vasodilator Drugs Sales Price by Application (2021-2026) & (USD/unit) Table 213. China Peripheral Vasodilator Drugs Sales Price by Application (2027-2032) & (USD/unit) Table 214. Asia Peripheral Vasodilator Drugs Revenue by Type (2021-2026) & (US$ Million) Table 215. Asia Peripheral Vasodilator Drugs Revenue by Type (2027-2032) & (US$ Million) Table 216. Asia Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (k units) Table 217. Asia Peripheral Vasodilator Drugs Sales by Type (2027-2032) & (k units) Table 218. Asia Peripheral Vasodilator Drugs Sales Price by Type (2021-2026) & (USD/unit) Table 219. Asia Peripheral Vasodilator Drugs Sales Price by Type (2027-2032) & (USD/unit) Table 220. Asia Peripheral Vasodilator Drugs Revenue by Application (2021-2026) & (US$ Million) Table 221. Asia Peripheral Vasodilator Drugs Revenue by Application (2027-2032) & (US$ Million) Table 222. Asia Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (k units) Table 223. Asia Peripheral Vasodilator Drugs Sales by Application (2027-2032) & (k units) Table 224. Asia Peripheral Vasodilator Drugs Sales Price by Application (2021-2026) & (USD/unit) Table 225. Asia Peripheral Vasodilator Drugs Sales Price by Application (2027-2032) & (USD/unit) Table 226. Asia Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. Asia Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. Asia Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. Asia Peripheral Vasodilator Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 230. Asia Peripheral Vasodilator Drugs Sales by Country (2021-2026) & (k units) Table 231. Asia Peripheral Vasodilator Drugs Sales by Country (2027-2032) & (k units) Table 232. Asia Peripheral Vasodilator Drugs Sales Price by Country (2021-2026) & (USD/unit) Table 233. Asia Peripheral Vasodilator Drugs Sales Price by Country (2027-2032) & (USD/unit) Table 234. Japan Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 235. South Korea Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 236. India Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 237. Australia Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 238. Taiwan Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 239. Southeast Asia Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 240. SAMEA Peripheral Vasodilator Drugs Revenue by Type (2021-2026) & (US$ Million) Table 241. SAMEA Peripheral Vasodilator Drugs Revenue by Type (2027-2032) & (US$ Million) Table 242. SAMEA Peripheral Vasodilator Drugs Sales by Type (2021-2026) & (k units) Table 243. SAMEA Peripheral Vasodilator Drugs Sales by Type (2027-2032) & (k units) Table 244. SAMEA Peripheral Vasodilator Drugs Sales Price by Type (2021-2026) & (USD/unit) Table 245. SAMEA Peripheral Vasodilator Drugs Sales Price by Type (2027-2032) & (USD/unit) Table 246. SAMEA Peripheral Vasodilator Drugs Revenue by Application (2021-2026) & (US$ Million) Table 247. SAMEA Peripheral Vasodilator Drugs Revenue by Application (2027-2032) & (US$ Million) Table 248. SAMEA Peripheral Vasodilator Drugs Sales by Application (2021-2026) & (k units) Table 249. SAMEA Peripheral Vasodilator Drugs Sales by Application (2027-2032) & (k units) Table 250. SAMEA Peripheral Vasodilator Drugs Sales Price by Application (2021-2026) & (USD/unit) Table 251. SAMEA Peripheral Vasodilator Drugs Sales Price by Application (2027-2032) & (USD/unit) Table 252. SAMEA Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 253. SAMEA Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 254. SAMEA Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 255. SAMEA Peripheral Vasodilator Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 256. SAMEA Peripheral Vasodilator Drugs Sales by Country (2021-2026) & (k units) Table 257. SAMEA Peripheral Vasodilator Drugs Sales by Country (2027-2032) & (k units) Table 258. SAMEA Peripheral Vasodilator Drugs Sales Price by Country (2021-2026) & (USD/unit) Table 259. SAMEA Peripheral Vasodilator Drugs Sales Price by Country (2027-2032) & (USD/unit) Table 260. Brazil Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 261. Argentina Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 262. Chile Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 263. Colombia Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 264. Peru Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 265. Saudi Arabia Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 266. Israel Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 267. UAE Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 268. Turkey Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 269. Iran Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 270. Egypt Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Table 271. Key Raw Materials Table 272. Raw Materials Key Suppliers Table 273. Peripheral Vasodilator Drugs Distributors List Table 274. Peripheral Vasodilator Drugs Customers List Table 275. Research Programs/Design for This Report Table 276. Authors List of This Report Table 277. Secondary Sources Table 278. Primary Sources List of Figures Figure 1. Peripheral Vasodilator Drugs Image Figure 2. Global Peripheral Vasodilator Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peripheral Vasodilator Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Alpha-adrenergic Blockers Image Figure 5. Calcium Channel Blockers Image Figure 6. Potassium Channel Activators Image Figure 7. Others Image Figure 8. Global Peripheral Vasodilator Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Peripheral Vasodilator Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Retail Pharmacies Image Figure 12. Others Image Figure 13. Global Peripheral Vasodilator Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Peripheral Vasodilator Drugs Revenue (2021-2032) & (US$ Million) Figure 15. Global Peripheral Vasodilator Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Peripheral Vasodilator Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Peripheral Vasodilator Drugs Revenue Market Share by Region (2021-2032) Figure 18. Global Peripheral Vasodilator Drugs Sales (2021-2032) & (k units) Figure 19. Global Peripheral Vasodilator Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Peripheral Vasodilator Drugs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Peripheral Vasodilator Drugs Sales YoY (2021-2032) & (k units) Figure 22. Europe Peripheral Vasodilator Drugs Sales YoY (2021-2032) & (k units) Figure 23. China Peripheral Vasodilator Drugs Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Peripheral Vasodilator Drugs Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Peripheral Vasodilator Drugs Sales YoY (2021-2032) & (k units) Figure 26. Global Peripheral Vasodilator Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Peripheral Vasodilator Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Peripheral Vasodilator Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Peripheral Vasodilator Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Peripheral Vasodilator Drugs Revenue Market Share by Type (2021-2032) Figure 32. Global Peripheral Vasodilator Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Peripheral Vasodilator Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Peripheral Vasodilator Drugs Sales Market Share by Type (2021-2032) Figure 35. Global Peripheral Vasodilator Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Peripheral Vasodilator Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Peripheral Vasodilator Drugs Revenue Market Share by Application (2021-2032) Figure 38. Global Peripheral Vasodilator Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Peripheral Vasodilator Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Peripheral Vasodilator Drugs Sales Market Share by Application (2021-2032) Figure 41. North America Peripheral Vasodilator Drugs Revenue Share by Type (2021-2032) Figure 42. North America Peripheral Vasodilator Drugs Sales Share by Type (2021-2032) Figure 43. North America Peripheral Vasodilator Drugs Revenue Share by Application (2021-2032) Figure 44. North America Peripheral Vasodilator Drugs Sales Share by Application (2021-2032) Figure 45. North America Peripheral Vasodilator Drugs Revenue Share by Country (2021-2032) Figure 46. North America Peripheral Vasodilator Drugs Sales Share by Country (2021-2032) Figure 47. Europe Peripheral Vasodilator Drugs Revenue Share by Type (2021-2032) Figure 48. Europe Peripheral Vasodilator Drugs Sales Share by Type (2021-2032) Figure 49. Europe Peripheral Vasodilator Drugs Revenue Share by Application (2021-2032) Figure 50. Europe Peripheral Vasodilator Drugs Sales Share by Application (2021-2032) Figure 51. Europe Peripheral Vasodilator Drugs Revenue Share by Country (2021-2032) Figure 52. Europe Peripheral Vasodilator Drugs Sales Share by Country (2021-2032) Figure 53. China Peripheral Vasodilator Drugs Revenue Share by Type (2021-2032) Figure 54. China Peripheral Vasodilator Drugs Sales Share by Type (2021-2032) Figure 55. China Peripheral Vasodilator Drugs Revenue Share by Application (2021-2032) Figure 56. China Peripheral Vasodilator Drugs Sales Share by Application (2021-2032) Figure 57. Asia Peripheral Vasodilator Drugs Revenue Share by Type (2021-2032) Figure 58. Asia Peripheral Vasodilator Drugs Sales Share by Type (2021-2032) Figure 59. Asia Peripheral Vasodilator Drugs Revenue Share by Application (2021-2032) Figure 60. Asia Peripheral Vasodilator Drugs Sales Share by Application (2021-2032) Figure 61. Asia Peripheral Vasodilator Drugs Revenue Share by Country (2021-2032) Figure 62. Asia Peripheral Vasodilator Drugs Sales Share by Country (2021-2032) Figure 63. SAMEA Peripheral Vasodilator Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA Peripheral Vasodilator Drugs Sales Share by Type (2021-2032) Figure 65. SAMEA Peripheral Vasodilator Drugs Revenue Share by Application (2021-2032) Figure 66. SAMEA Peripheral Vasodilator Drugs Sales Share by Application (2021-2032) Figure 67. SAMEA Peripheral Vasodilator Drugs Revenue Share by Country (2021-2032) Figure 68. SAMEA Peripheral Vasodilator Drugs Sales Share by Country (2021-2032) Figure 69. Peripheral Vasodilator Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Peripheral Vasodilator Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Alpha-adrenergic Blockers
  • Calcium Channel Blockers
  • Potassium Channel Activators
  • Others
Applications
  • Hospital
  • Retail Pharmacies
  • Others
Companies covered
  • Endovastec
  • Aotecar Medical-B
  • Tibet Cheezheng Tibetan Medicine Co., Ltd
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Novartis AG
  • Pfizer, Inc.
  • GSK plc
  • Bayer AG
  • Bat Medical
  • AstraZeneca
  • Viatris, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Lupin
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim International GmbH
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Peripheral Vasodilator Drugs Market by Type
  3. 1.2.1 Global Peripheral Vasodilator Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Alpha-adrenergic Blockers
  5. 1.2.3 Calcium Channel Blockers
  6. 1.2.4 Potassium Channel Activators
  7. 1.2.5 Others
  8. 1.3 Peripheral Vasodilator Drugs Market by Application
  9. 1.3.1 Global Peripheral Vasodilator Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Retail Pharmacies
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Peripheral Vasodilator Drugs Market Dynamics
  1. 2.1 Peripheral Vasodilator Drugs Industry Trends
  2. 2.2 Peripheral Vasodilator Drugs Industry Drivers
  3. 2.3 Peripheral Vasodilator Drugs Industry Opportunities and Challenges
  4. 2.4 Peripheral Vasodilator Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Peripheral Vasodilator Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Peripheral Vasodilator Drugs Revenue by Region
  3. 3.2.1 Global Peripheral Vasodilator Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Peripheral Vasodilator Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Peripheral Vasodilator Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Peripheral Vasodilator Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Peripheral Vasodilator Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Peripheral Vasodilator Drugs Sales by Region
  9. 3.4.1 Global Peripheral Vasodilator Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Peripheral Vasodilator Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Peripheral Vasodilator Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Peripheral Vasodilator Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Peripheral Vasodilator Drugs Revenue by Manufacturers
  2. 4.1.1 Global Peripheral Vasodilator Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Peripheral Vasodilator Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Peripheral Vasodilator Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Peripheral Vasodilator Drugs Sales by Manufacturers
  6. 4.2.1 Global Peripheral Vasodilator Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Peripheral Vasodilator Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Peripheral Vasodilator Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Peripheral Vasodilator Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Peripheral Vasodilator Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Peripheral Vasodilator Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Peripheral Vasodilator Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Peripheral Vasodilator Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Peripheral Vasodilator Drugs Market CR5 and HHI
  16. 4.8.2 2025 Peripheral Vasodilator Drugs Tier 1, Tier 2, and Tier 3
5 Peripheral Vasodilator Drugs Market by Type
  1. 5.1 Global Peripheral Vasodilator Drugs Revenue by Type
  2. 5.1.1 Global Peripheral Vasodilator Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Peripheral Vasodilator Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Peripheral Vasodilator Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Peripheral Vasodilator Drugs Sales by Type
  6. 5.2.1 Global Peripheral Vasodilator Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Peripheral Vasodilator Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Peripheral Vasodilator Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Peripheral Vasodilator Drugs Price by Type
6 Peripheral Vasodilator Drugs Market by Application
  1. 6.1 Global Peripheral Vasodilator Drugs Revenue by Application
  2. 6.1.1 Global Peripheral Vasodilator Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Peripheral Vasodilator Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Peripheral Vasodilator Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Peripheral Vasodilator Drugs Sales by Application
  6. 6.2.1 Global Peripheral Vasodilator Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Peripheral Vasodilator Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Peripheral Vasodilator Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Peripheral Vasodilator Drugs Price by Application
7 Company Profiles
  1. 7.1 Endovastec
  2. 7.1.1 Endovastec Company Information
  3. 7.1.2 Endovastec Business Overview
  4. 7.1.3 Endovastec Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Endovastec Peripheral Vasodilator Drugs Product Portfolio
  6. 7.1.5 Endovastec Recent Developments
  7. 7.2 Aotecar Medical-B
  8. 7.2.1 Aotecar Medical-B Company Information
  9. 7.2.2 Aotecar Medical-B Business Overview
  10. 7.2.3 Aotecar Medical-B Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aotecar Medical-B Peripheral Vasodilator Drugs Product Portfolio
  12. 7.2.5 Aotecar Medical-B Recent Developments
  13. 7.3 Tibet Cheezheng Tibetan Medicine Co., Ltd
  14. 7.3.1 Tibet Cheezheng Tibetan Medicine Co., Ltd Company Information
  15. 7.3.2 Tibet Cheezheng Tibetan Medicine Co., Ltd Business Overview
  16. 7.3.3 Tibet Cheezheng Tibetan Medicine Co., Ltd Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Tibet Cheezheng Tibetan Medicine Co., Ltd Peripheral Vasodilator Drugs Product Portfolio
  18. 7.3.5 Tibet Cheezheng Tibetan Medicine Co., Ltd Recent Developments
  19. 7.4 Teva Pharmaceutical Industries Ltd.
  20. 7.4.1 Teva Pharmaceutical Industries Ltd. Company Information
  21. 7.4.2 Teva Pharmaceutical Industries Ltd. Business Overview
  22. 7.4.3 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product Portfolio
  24. 7.4.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  25. 7.5 Sanofi
  26. 7.5.1 Sanofi Company Information
  27. 7.5.2 Sanofi Business Overview
  28. 7.5.3 Sanofi Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanofi Peripheral Vasodilator Drugs Product Portfolio
  30. 7.5.5 Sanofi Recent Developments
  31. 7.6 Novartis AG
  32. 7.6.1 Novartis AG Company Information
  33. 7.6.2 Novartis AG Business Overview
  34. 7.6.3 Novartis AG Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Novartis AG Peripheral Vasodilator Drugs Product Portfolio
  36. 7.6.5 Novartis AG Recent Developments
  37. 7.7 Pfizer, Inc.
  38. 7.7.1 Pfizer, Inc. Company Information
  39. 7.7.2 Pfizer, Inc. Business Overview
  40. 7.7.3 Pfizer, Inc. Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer, Inc. Peripheral Vasodilator Drugs Product Portfolio
  42. 7.7.5 Pfizer, Inc. Recent Developments
  43. 7.8 GSK plc
  44. 7.8.1 GSK plc Company Information
  45. 7.8.2 GSK plc Business Overview
  46. 7.8.3 GSK plc Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GSK plc Peripheral Vasodilator Drugs Product Portfolio
  48. 7.8.5 GSK plc Recent Developments
  49. 7.9 Bayer AG
  50. 7.9.1 Bayer AG Company Information
  51. 7.9.2 Bayer AG Business Overview
  52. 7.9.3 Bayer AG Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Bayer AG Peripheral Vasodilator Drugs Product Portfolio
  54. 7.9.5 Bayer AG Recent Developments
  55. 7.10 Bat Medical
  56. 7.10.1 Bat Medical Company Information
  57. 7.10.2 Bat Medical Business Overview
  58. 7.10.3 Bat Medical Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Bat Medical Peripheral Vasodilator Drugs Product Portfolio
  60. 7.10.5 Bat Medical Recent Developments
  61. 7.11 AstraZeneca
  62. 7.11.1 AstraZeneca Company Information
  63. 7.11.2 AstraZeneca Business Overview
  64. 7.11.3 AstraZeneca Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 AstraZeneca Peripheral Vasodilator Drugs Product Portfolio
  66. 7.11.5 AstraZeneca Recent Developments
  67. 7.12 Viatris, Inc.
  68. 7.12.1 Viatris, Inc. Company Information
  69. 7.12.2 Viatris, Inc. Business Overview
  70. 7.12.3 Viatris, Inc. Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Viatris, Inc. Peripheral Vasodilator Drugs Product Portfolio
  72. 7.12.5 Viatris, Inc. Recent Developments
  73. 7.13 Sun Pharmaceutical Industries Ltd.
  74. 7.13.1 Sun Pharmaceutical Industries Ltd. Company Information
  75. 7.13.2 Sun Pharmaceutical Industries Ltd. Business Overview
  76. 7.13.3 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product Portfolio
  78. 7.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  79. 7.14 Merck & Co., Inc.
  80. 7.14.1 Merck & Co., Inc. Company Information
  81. 7.14.2 Merck & Co., Inc. Business Overview
  82. 7.14.3 Merck & Co., Inc. Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Merck & Co., Inc. Peripheral Vasodilator Drugs Product Portfolio
  84. 7.14.5 Merck & Co., Inc. Recent Developments
  85. 7.15 Lupin
  86. 7.15.1 Lupin Company Information
  87. 7.15.2 Lupin Business Overview
  88. 7.15.3 Lupin Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Lupin Peripheral Vasodilator Drugs Product Portfolio
  90. 7.15.5 Lupin Recent Developments
  91. 7.16 Bristol-Myers Squibb Company
  92. 7.16.1 Bristol-Myers Squibb Company Company Information
  93. 7.16.2 Bristol-Myers Squibb Company Business Overview
  94. 7.16.3 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Product Portfolio
  96. 7.16.5 Bristol-Myers Squibb Company Recent Developments
  97. 7.17 Boehringer Ingelheim International GmbH
  98. 7.17.1 Boehringer Ingelheim International GmbH Company Information
  99. 7.17.2 Boehringer Ingelheim International GmbH Business Overview
  100. 7.17.3 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Product Portfolio
  102. 7.17.5 Boehringer Ingelheim International GmbH Recent Developments
  103. 7.18 Abbott Laboratories
  104. 7.18.1 Abbott Laboratories Company Information
  105. 7.18.2 Abbott Laboratories Business Overview
  106. 7.18.3 Abbott Laboratories Peripheral Vasodilator Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Abbott Laboratories Peripheral Vasodilator Drugs Product Portfolio
  108. 7.18.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Peripheral Vasodilator Drugs Market Size by Type
  2. 8.1.1 North America Peripheral Vasodilator Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Peripheral Vasodilator Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Peripheral Vasodilator Drugs Price by Type (2021-2032)
  5. 8.2 North America Peripheral Vasodilator Drugs Market Size by Application
  6. 8.2.1 North America Peripheral Vasodilator Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Peripheral Vasodilator Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Peripheral Vasodilator Drugs Price by Application (2021-2032)
  9. 8.3 North America Peripheral Vasodilator Drugs Market Size by Country
  10. 8.3.1 North America Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Peripheral Vasodilator Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Peripheral Vasodilator Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Peripheral Vasodilator Drugs Market Size by Type
  2. 9.1.1 Europe Peripheral Vasodilator Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Peripheral Vasodilator Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Peripheral Vasodilator Drugs Price by Type (2021-2032)
  5. 9.2 Europe Peripheral Vasodilator Drugs Market Size by Application
  6. 9.2.1 Europe Peripheral Vasodilator Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Peripheral Vasodilator Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Peripheral Vasodilator Drugs Price by Application (2021-2032)
  9. 9.3 Europe Peripheral Vasodilator Drugs Market Size by Country
  10. 9.3.1 Europe Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Peripheral Vasodilator Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Peripheral Vasodilator Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Peripheral Vasodilator Drugs Market Size by Type
  2. 10.1.1 China Peripheral Vasodilator Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Peripheral Vasodilator Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Peripheral Vasodilator Drugs Price by Type (2021-2032)
  5. 10.2 China Peripheral Vasodilator Drugs Market Size by Application
  6. 10.2.1 China Peripheral Vasodilator Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Peripheral Vasodilator Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Peripheral Vasodilator Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Peripheral Vasodilator Drugs Market Size by Type
  2. 11.1.1 Asia Peripheral Vasodilator Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Peripheral Vasodilator Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Peripheral Vasodilator Drugs Price by Type (2021-2032)
  5. 11.2 Asia Peripheral Vasodilator Drugs Market Size by Application
  6. 11.2.1 Asia Peripheral Vasodilator Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Peripheral Vasodilator Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Peripheral Vasodilator Drugs Price by Application (2021-2032)
  9. 11.3 Asia Peripheral Vasodilator Drugs Market Size by Country
  10. 11.3.1 Asia Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Peripheral Vasodilator Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Peripheral Vasodilator Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Peripheral Vasodilator Drugs Market Size by Type
  2. 12.1.1 SAMEA Peripheral Vasodilator Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Peripheral Vasodilator Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Peripheral Vasodilator Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Peripheral Vasodilator Drugs Market Size by Application
  6. 12.2.1 SAMEA Peripheral Vasodilator Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Peripheral Vasodilator Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Peripheral Vasodilator Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Peripheral Vasodilator Drugs Market Size by Country
  10. 12.3.1 SAMEA Peripheral Vasodilator Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Peripheral Vasodilator Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Peripheral Vasodilator Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Peripheral Vasodilator Drugs Value Chain Analysis
  2. 13.1.1 Peripheral Vasodilator Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Peripheral Vasodilator Drugs Production Mode & Process
  6. 13.2 Peripheral Vasodilator Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Peripheral Vasodilator Drugs Distributors
  9. 13.2.3 Peripheral Vasodilator Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst